{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:41:33Z","timestamp":1789764093789,"version":"4.0.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Dev Behav Pediatr"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Early diagnosis of Duchenne muscular dystrophy (DMD) is important for timely intervention to prolong function and preserve quality of life. The prevalence of various neurocognitive disorders is known to be higher in patients with DMD than the general population. In this study, we highlight cases of delayed DMD diagnosis that resulted from misattribution of early motor symptoms to co-occurring neurocognitive conditions. We also investigate the difference in age at DMD diagnosis in the setting of specific co-occurring neurocognitive conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method:<\/jats:title>\n                    <jats:p>In this study, we reviewed 40 consecutive patients seen at a Certified Duchenne Care Center, excluding siblings of already-diagnosed patients. We highlight cases of significant delay in DMD diagnosis in the setting of co-occurring neurocognitive diagnoses. We also investigate the association of autism spectrum disorder (ASD), attention-deficit\/hyperactivity disorder (ADHD), intellectual disability, and speech\/language delay on age of DMD diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The prevalence of co-occurring neurocognitive diagnoses was 73.1% in patients diagnosed at or after age 5 years vs. 35.7% in those diagnosed before age 5 years. The average age of DMD diagnosis was 6.6 years in patients with any co-occurring neurocognitive diagnoses and 4.9 years in patients without (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.09). Individual analysis of ASD and ADHD showed significant differences. A greater number of co-occurring conditions were associated with an increased age at DMD diagnosis (\n                      <jats:italic toggle=\"yes\">R<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 0.87,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The data suggest an association between the presence of co-occurring neurocognitive conditions and a later age of DMD diagnosis. One cost-effective diagnostic step that can be implemented by all pediatric practitioners is testing serum creatinine kinase (CK) in any child with motor delays or hypotonia, even in the context of other behavioral or cognitive disabilities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/dbp.0000000000001105","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T12:01:24Z","timestamp":1657108884000},"page":"e541-e545","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["The Hidden Disease: Delayed Diagnosis in Duchenne Muscular Dystrophy and Co-Occurring Conditions"],"prefix":"10.1097","volume":"43","author":[{"given":"Irene","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassie","family":"Turnage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Sutyla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel","family":"Lindahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Jesus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3381-5594","authenticated-orcid":false,"given":"Rebecca J.","family":"Scharf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"R1-20260212","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol."},{"key":"R2-20260212","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.nmd.2014.03.008","article-title":"A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy","volume":"24","author":"Mah","year":"2014","journal-title":"Neuromuscul Disord."},{"key":"R3-20260212","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.2147\/NDT.S93873","article-title":"Current and emerging treatment strategies for Duchenne muscular dystrophy","volume":"12","author":"Mah","year":"2016","journal-title":"Neuropsychiatr Dis Treat."},{"key":"R4-20260212","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol."},{"key":"R5-20260212","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1017\/S1355617717001333","article-title":"Executive skills and academic achievement in the dystrophinopathies","volume":"24","author":"Fee","year":"2018","journal-title":"J Int Neuropsychologic Soc."},{"key":"R6-20260212","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1017\/S1355617718000942","article-title":"Executive functioning in the dystrophinopathies and the relation to underlying mutation position","volume":"25","author":"Fee","year":"2019","journal-title":"J Int Neuropsychologic Soc."},{"key":"R7-20260212","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4081\/ni.2018.7473","article-title":"Cognitive impairment in neuromuscular diseases: a systematic review","volume":"10","author":"Orsini","year":"2018","journal-title":"Neurol Int."},{"key":"R8-20260212","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/0883073807309775","article-title":"Neuropsychiatric disorders in males with Duchenne muscular dystrophy: frequency rate of attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder, and obsessive-compulsive disorder","volume":"23","author":"Hendriksen","year":"2008","journal-title":"J Child Neurol."},{"key":"R9-20260212","doi-asserted-by":"crossref","first-page":"233","DOI":"10.23736\/S0026-4946.16.04380-2","article-title":"Autism spectrum disorders in children affected by Duchenne muscular dystrophy","volume":"70","author":"Parisi","year":"2018","journal-title":"Minerva Pediatr."},{"key":"R10-20260212","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1016\/j.nmd.2015.06.059","article-title":"Addressing discrepancies in care with the certified Duchenne care center program","volume":"25","author":"Kinnett","year":"2015","journal-title":"Neuromuscul Disord."},{"key":"R11-20260212","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.nmd.2016.09.007","article-title":"The certified Duchenne care center program","volume":"26","author":"Kinnett","year":"2016","journal-title":"Neuromuscul Disord."},{"key":"R12-20260212","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mus.26720","article-title":"Delays in diagnosis of Duchenne muscular dystrophy: an evaluation of genotypic and sociodemographic factors","volume":"61","author":"Counterman","year":"2020","journal-title":"Muscle Nerve"},{"key":"R13-20260212","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1136\/archdischild-2014-306366","article-title":"Improving recognition of Duchenne muscular dystrophy: a retrospective case note review","volume":"99","author":"van Ruiten","year":"2014","journal-title":"Arch Dis Child."},{"key":"R14-20260212","doi-asserted-by":"crossref","DOI":"10.1002\/mus.27532","article-title":"Time to diagnosis of Duchenne muscular dystrophy remains unchanged: findings from the muscular dystrophy surveillance, tracking, and research network (MD STARnet), 2000-2015","author":"Thomas","year":"2022","journal-title":"Muscle Nerve."},{"key":"R15-20260212","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/j.nmd.2020.08.062","article-title":"Has the time to diagnosis of Duchenne muscular dystrophy improved? Data from the muscular dystrophy surveillance, tracking, and research network","volume":"30","author":"Ciafaloni","year":"2020","journal-title":"Neuromuscul Disord."},{"key":"R16-20260212","doi-asserted-by":"crossref","first-page":"e20190811","DOI":"10.1542\/peds.2019-0811","article-title":"Prevalence and trends of developmental disabilities among children in the United States: 2009-2017","volume":"144","author":"Zablotsky","year":"2019","journal-title":"Pediatrics"},{"key":"R17-20260212","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s40291-017-0309-5","article-title":"Cost effectiveness of karyotyping, chromosomal microarray analysis, and targeted next-generation sequencing of patients with unexplained global developmental delay or intellectual disability","volume":"22","author":"Li","year":"2018","journal-title":"Mol Diagn Ther."},{"key":"R18-20260212","first-page":"S12","article-title":"Genetic counseling in dystrophinopathies","volume":"22","author":"Coubes","year":"2015","journal-title":"Arch De Pediatrie"},{"key":"R19-20260212","doi-asserted-by":"crossref","first-page":"E2016","DOI":"10.1542\/peds.2013-1056","article-title":"Motor delays: early identification and evaluation","volume":"131","author":"Noritz","year":"2013","journal-title":"Pediatrics."},{"key":"R20-20260212","doi-asserted-by":"crossref","first-page":"E2146","DOI":"10.1212\/WNL.0000000000005680","article-title":"Eteplirsen treatment for Duchenne muscular dystrophy exon skipping and dystrophin production","volume":"90","author":"Charleston","year":"2018","journal-title":"Neurology."},{"key":"R21-20260212","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1089\/hum.2019.29103.jrm","article-title":"Translational medicine: evolution, fulfillment, and belief in gene therapy","volume":"31","author":"Mendell","year":"2020","journal-title":"Hum Gene Ther."},{"key":"R22-20260212","doi-asserted-by":"crossref","first-page":"8935","DOI":"10.3390\/ijms21238935","article-title":"From mice to humans: an overview of the potentials and limitations of current transgenic mouse models of major muscular dystrophies and congenital myopathies","volume":"21","author":"Sztretye","year":"2020","journal-title":"Int J Mol Sci."}],"container-title":["Journal of Developmental &amp; Behavioral Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DBP.0000000000001105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:00:52Z","timestamp":1770904852000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DBP.0000000000001105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/dbp.0000000000001105","relation":{},"ISSN":["0196-206X"],"issn-type":[{"value":"0196-206X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,6]]},"assertion":[{"value":"2021-11-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}